Acute diseases respiratory distress syndrome

Once one knows the problem and has devised a solution, then the real job begins. National Center for Health Statistics data show a decline in total US infant mortality from 1982 to 1992, but marked geographic and racial differences remain. The 1992 overall US rate of infant death was 8.5 per 1000 live births (California, 6.9 Texas, 7.7 New York, 8.5 New Jersey, 8.5 Pennsylvania, 8.6 Ohio, 8.7 Florida, 9.1 Illinois, 10.0 Georgia, 10.4 Michigan, 10.5) - a decline attributed not to reductions in the numbers of birth defects or premature births but to improved neonatal intensive care units and the introduction of synthetic pulmonary surfactants and consequent reductions in death from acute neonatal respiratory distress syndrome. Still, the years of potential life lost due to birth defects ranks fifth, just behind that of homicide and suicide (1, unintentional injury 2, cancer 3, cardiovascular disease) prematurity/low birth weight ranks sixth and sudden infant death syndrome seventh. Ethnic discrepancy remains pronounced rates of White (5.8 per 1000 live births) and Cuban Hispanic (3.7 per 1000 live births) infant death are similar, but the 2002 rate for Blacks (13.9 per 1000 live births) increased compared to the previous year. 

Phagocyte-derived ROMs have been implicated in the pathogenesis of a number of pulmonary diseases, including emphysema, acute respiratory distress syndrome, and various environmental diseases such as asbestos-related fibrosis and cancer (Mossman and Marsh, 1985). The relatively high oxygen tension in pulmonary tissue renders the lung prone to oxidative stress (Edwards and Lloyd, 1988). 

Lung tissue injury is also mediated by reactive oxygen and nitrogen species in another inflammatory lung disease, acute respiratory distress syndrome (ARDS) [267], Lamb et al. 

The following factors have been suggested as alternatives to consider when presented with a potential case of exposure to carbon monoxide diabetic ketoacidosis, hypothyroidism and myxedema coma, labyrinthitis, and lactic acidosis toxic exposures resulting in methemoglobinemia ingestion of alcohols or narcotics and diseases that cause gastroenteritis, encephalitis, meningitis, and acute respiratory distress syndrome. 

Suggested Alternatives for Differential Diagnosis Scarlet fever, cellulitis, cat scratch disease, gas gangrene, necrotizing fasciitis, tick-borne diseases such as Rocky Mountain spotted fever, pneumonia, septic shock, acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation. 

Disease state-specific formulations are designed to meet specific nutrient requirements and to manage metabolic abnormalities. Unfortunately, scientific and clinical research supporting their efficacy is minimal, except for low carbohydrate formulations supplemented with specific fatty acids and antioxidants for patients with acute respiratory distress syndrome. Oral supplements are not intended for tube feeding. They are sweetened to improve taste and are therefore hypertonic. 

Unlabeled Uses Cardiopulmonary bypass surgery hemodialysis pulmonary hypertension associated with acute respiratory distress syndrome, systemic lupus erythematosus, or congenital heart disease refractory CHF severe community-acquired pneumonia... 

When air is exhaled the small alveoli of the lungs could collapse if it were not for the surface active material (surfactant) present in the fluid that coats the lungs. e In fact, the lack of adequate surfactant is the cause of respiratory distress syndrome, a major cause of death among premature infants and a disease that may develop in acute form in adults. The surfactant material forms a thin film of high fluidity at the air-liquid interface and lowers the surface tension from the 72 mN/m of pure water to <10 mN/mfs (Pay attention to the definition of surface tension.11)... 

In particular, excessive proteolysis of elastin by HLE has been implicated in pulmonary emphysema [19]. In this case, the imbalance appears to result from reduced levels of active extracellular alpha,-proteinase inhibitor (a,-PI), the primary plasma inhibitor of HLE. This decrease is caused either by a genetic disorder (PiZZ phenotype individuals) or by reduction in the elastase inhibitory capacity (EIC) of ai-PI due to its oxidative inactivation by tobacco smoke [20]. The detailed evidence supporting the potential role of elastase in the development of emphysema has been extensively reviewed [21] and will not be repeated here. The fact that HLE is also a potent secretagogue [22] may play a role in several disease states, including cystic fibrosis [23], chronic bronchitis [24], and acute respiratory distress syndrome (ARDS) [25]. The mechanism of the secretagogue activity is not known, but, since the HLE-induced secretion can be blocked by specific HLE inhibitors, it appears to require catalytic activity by the enzyme [26]. 

Delayed reactions are defined by the occurrence of arthralgia and joint stiffness (that is a serum sicknesslike reaction) in the days after infliximab administration they have mostly been observed in patients with Crohn s disease who have received episodic treatment. In one patient the complication was associated with acute respiratory distress syndrome, which only became evident 10 days after re-treatment (22). 

A close association has been described for IL-8 and other CXCRl/2 ligands in acute inflammation, including neutrophil-mediated inflammatory diseases such as ischemia-reperfusion injury, bacterial pneumonia, adult respiratory distress syndrome, and other infectious diseases. Neutralization of IL-8 in rabbits has shown dramatic protection in several models of neutrophil-mediated acute inflammation (261,262). 

Mustard gas exposure also causes inflammatory lung diseases, including acute respiratory distress syndrome (ARDS) (Calvet et al., 1994 Sohrabpour, 1984). A defective secretion of surfactant by alveolar type 11 cells has been implicated as one of the causative factors for the development of ARDS (Ansceschi, 1989). A major component of lung surfactant is DPPC (Stith and Das, 1982). The precursor of DPPC is normally l-pahnitoyl-2-oleolyl PC. DPPC is produced by deacylation and subsequent reacylation with palmitic acid at 2-position of glycerol moiety of the unsaturated phospholipid. 

Unbalanced production of reactive oxygen species, first of aU superoxide and hydrogen peroxide, has been postulated as playing a role in the pathogenesis of a number of chnical disorders, such as acute respiratory distress syndrome, ischemia-reperfusion injury, atherosclerosis, neurodegenerative diseases and cancer. As the function of SOD and CAT is the protection against oxidative stress, their apphcation has been proposed in cases where oxidative stress is important in the mechanism of a disease. 

This chapter addresses the problems of acute respiratory distress syndromes in neonates, children, and adults. Abbreviations are used throughout the text, and a glossary for physiology, diseases, and drugs is presented in Table 28-1. Descriptions of ventilator-related terms are provided in Tables 28-2 and 28-3. Because the physiology of neonatal respiratory distress syndrome (RDS) and acute respiratory distress syndrome (ARDS) has some differences, these diseases will be discussed separately. 

American Lung Association. Acute respiratory distress syndrome. In Lung Disease Data, 1998-1999. New York, American Lung Association. 1998 45-46. 

Multiple studies have addressed the role of thyroid supplementation in critically ill patients with cardiac disease, sepsis, pulmonary disease (e.g., acute respiratory distress syndrome), or severe infection, or with burn and trauma patients. In spite of a very large number of published studies, it is very difficult to form clear recommendations for treatment with thyroid hormone in the intensive care unit. 

Gene therapy is under development for a variety of lung diseases, both those caused by single-gene defects, such as cystic fibrosis and ttj-antitrypsin deficiency and multifactorial disease, such as cancer, asthma, lung fibrosis, and acute respiratory distress syndrome (ARDS). Both viral and non-viral approaches have been explored, the major limitation of the former being the inability to repeatedly administer. 

In contrast, drugs that release endogenous nitric oxide and donors of the molecule were in use long before nitric oxide was discovered and continue to be very important in clinical medicine. The cardiovascular applications of nitroprusside (Chapter 11) and the nitrates and nitrites (Chapter 12) have been discussed. The treatments of preeclampsia and of pulmonary hypertension and acute respiratory distress syndrome are currently under clinical investigation. Early results from the pulmonary disease studies appear promising, and one preparation of nitric oxide gas (INOmax) has been approved for use in neonates with hypoxic respiratory failure. 

---